Nanomedicine News

RSS
BIND Therapeutics Provides Business Highlights and Financial Results for First Quarter 2015

BIND Therapeutics Provides Business Highlights and Financial Results for First Quarter 2015

Researchers Study Nanoscale Drug Vesicles to Determine Precise Dynamics of Crystallization

Researchers Study Nanoscale Drug Vesicles to Determine Precise Dynamics of Crystallization

New Commercially Viable Technique to Create Longer Custom-Designed Strands of DNA

New Commercially Viable Technique to Create Longer Custom-Designed Strands of DNA

Loading Antigens into Silicon Microparticles Could Boost Effectiveness of Cancer Vaccines

Loading Antigens into Silicon Microparticles Could Boost Effectiveness of Cancer Vaccines

Immune and STC Collaborate to Develop Antibody Nanoparticle Conjugates for Targeted Chemo-Therapeutics Delivery

Immune and STC Collaborate to Develop Antibody Nanoparticle Conjugates for Targeted Chemo-Therapeutics Delivery

Exosomes Deliver Potent Antioxidant to the Brain to Treat Parkinson's Disease

Exosomes Deliver Potent Antioxidant to the Brain to Treat Parkinson's Disease

Beam Tracking with Mirror Tip- and Tilting Piezostage PKS1

Beam Tracking with Mirror Tip- and Tilting Piezostage PKS1

LGC Workshop in Teddington to Mark End of Three-Year NanoChOp Project

LGC Workshop in Teddington to Mark End of Three-Year NanoChOp Project

NJHF Grant for Studies Evaluating Effects of Nanofiber Coating on Soft Tissue Regeneration

NJHF Grant for Studies Evaluating Effects of Nanofiber Coating on Soft Tissue Regeneration

Celsion Provides Update on Clinical Development Plans for GEN-1 Ovarian Cancer DNA-Based Immunotherapy

Celsion Provides Update on Clinical Development Plans for GEN-1 Ovarian Cancer DNA-Based Immunotherapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.